Compare Amgen, Inc. (AMGN) vs United Microelectronics Corp (UMC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Amgen, Inc. vs United Microelectronics Corp — how do they compare? Amgen, Inc. trades at $363.66 (market cap $196.12B), while United Microelectronics Corp trades at $23.87 (market cap $61.20B). The key difference: Amgen, Inc. is far larger — about 3.2× United Microelectronics Corp's market cap, and Amgen, Inc. pays the higher dividend (2.77%). Which is the better fit depends on your goals.
| AMGN | UMC | |
|---|---|---|
Market Cap | $196.12B | $61.20B |
Sector | Health | Technology |
52-Week High | $388.16 | $28.02 |
52-Week Low | $271.18 | $6.58 |
Enterprise Value | $241.41B | $58.77B |
Dividend Yield | 2.77% | 1.69% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMGN trades at $363.39, down slightly by 0.06% today, with a bullish technical signal from moving averages. The company reported strong Q1 2026 earnings, beating estimates with EPS of $5.15 versus $4.77 expected. Revenue grew to $36.75B in 2025, with a net income margin of 20.96%. Recent news includes a favorable court ruling blocking a price cap on Enbrel in Colorado, but regulatory challenges persist for Tavneos in Europe.
The outlook remains positive due to consistent earnings beats and a diversified product portfolio, though risks include regulatory setbacks and competitive pressures. Analyst consensus is bullish with a 57.9% buy rating and a price target of $357.38, slightly below the current price, indicating potential for stability with upside from pipeline developments.
UMC trades at $24.34, down 2.09% today, with a bullish technical signal from moving averages and neutral oscillators. Revenue grew to $237.55B in 2025, though net income margin compressed to 16.99%. Recent June 2026 sales rose 22.85% year-over-year, and the company launched a 14nm eHV FinFET platform for display drivers. Analyst consensus is mixed with 27% buy ratings, while institutional sentiment leans positive amid AI and automotive chip demand.
Outlook: UMC benefits from specialty semiconductor demand, but high P/E of 39.52 and margin pressures pose valuation risks. Earnings beats and dividend payments support income investors, yet competition and cyclical industry volatility require caution for growth-focused shareholders.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amgen, Inc.
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Read more on AMGN →About United Microelectronics Corp
Founded in 1980, United Microelectronics is the world's third-largest dedicated chip foundry, with 7% market share in 2021, according to Gartner, after TSMC and GlobalFoundries. UMC's headquarters are in Hsinchu, Taiwan, and it operates 12 fabs in Taiwan, Mainland China, Japan and Singapore, with additional sales offices in Europe, the U.S. and South Korea. UMC features a diverse customer base including Texas Instruments, MediaTek, Qualcomm, Broadcom, Xilinx and Realtek, supplying a wide range of products applied in communications, display, memory, automotive and more. UMC employs about 20,000 people.
Read more on UMC →
